Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts and notes receivable credit period. Accounts And Notes Receivable Credit Period Number of years from effective date to receive note advances Accounts Payable Current Accounts payable Accretion Amortization Of Discounts And Premiums Investments Amortization of premium (discount) on available-for-sale securities Accrued clinical trial expenses Accrued Clinical Trial Expenses Accrued clinical trial expenses Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated other comprehensive income Additional Paid In Capital Common Stock Additional paid-in-capital Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Allegro stockholders. Allegro Stockholders [Member] Allegro stockholders [Member] Amendment Flag Amendment Flag Amortization Of Financing Costs And Discounts Amortization of debt discount, deferred interest and right-to-borrow asset Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Anti-dilutive securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Arrangements And Nonarrangement Transactions [Member] Arrangements and Non-arrangement Transactions [Domain] Assets Total assets Assets [Abstract] ASSETS Assets Current Total current assets Assets Current [Abstract] Current assets: Assets Fair Value Disclosure [Abstract] Assets Assets Fair Value Disclosure Recurring Total assets Autoliv ASP, Inc. Autoliv Asp Inc [Member] Autoliv ASP, Inc. [Member] Available convertible term loan amount. Available Convertible Term Loan Amount Aggregate term loan advances Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax Unrealized Gain/(Loss) Available For Sale Securities Amortized Cost Amortized Cost Available For Sale Securities Current Marketable securities Fair Value This is the average balance during the period for securitized loans only (across all types of loans). Average Balance During Period Of Loan Securitized Sale of notes backed by royalty and milestone payments Award Type [Axis] Award Type [Axis] Basis Of Accounting Policy Policy [Text Block] Basis of Presentation Business Acquisition Acquiree [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition [Axis] Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability 1 Change in fair value of contingent consideration liability Increase (decrease) on change in fair value of contingent consideration liability (Loss)/gain on change in fair value of contingent consideration liability Business Combination Contingent Consideration Liability Current Current portion of contingent consideration liability Business Combination Contingent Consideration Liability Noncurrent Noncurrent portion of contingent consideration liability Cancelled unsecured debt. Cancelled Unsecured Debt Value of cancelled note Cash And Cash Equivalents At Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Cash And Cash Equivalents Fair Value Disclosure Cash and Cash Equivalents, Fair Value Disclosure Less amounts classified as cash equivalents, Fair Value Cash And Cash Equivalents Period Increase Decrease Net increase (decrease) in cash and cash equivalents Cash Cash Equivalents And Investments [Line Items] Cash Cash Equivalents And Investments [Line Items] Cash Cash Equivalents And Investments [Line Items] Cash Cash Equivalents And Investments [Table] Cash Cash Equivalents And Investments [Table] Cash Cash Equivalents And Investments [Table] Cash Equivalents Amortized Cost Cash Equivalents Amortized Cost Less amounts classified as cash equivalents, Amortized Cost Cash Equivalents Unrealized Gain Loss Cash Equivalents Unrealized Gain Loss Less amounts classified as cash equivalents, Unrealized Gain/(Loss) Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Non cash investing and financing activities: Class Of Warrant Or Right Contractual Term Of Warrants Or Rights Class Of Warrant Or Right Contractual Term Of Warrants Or Rights Warrant exercisable term Class Of Warrant Or Right Exercise Price Of Warrants Or Rights 1 Price of common stock per share Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Warrants to purchase common stock Collaborative Arrangement Disclosure [Text Block] License Agreements Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Common Stock Capital Shares Reserved For Future Issuance Shares available for issuance under the ESPP Common Stock Value Common stock Consolidation Policy [Text Block] Basis of Consolidation Convertible Debt Securities [Member] Convertible debt [Member] Corporate Debt Securities [Member] Corporate debt securities [Member] Cost Of Goods Sold Cost of goods sold Costs And Expenses Total operating expenses Costs And Expenses [Abstract] Operating expenses: Current Fiscal Year End Date Current Fiscal Year End Date Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Financing Obligations Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument Convertible Conversion Price 1 Debt instrument conversion price per share Debt Instrument Date Of First Required Payment 1 First quarterly interest payment Debt Instrument Interest Rate Effective Percentage Effective interest rate of notes Debt Instrument Interest Rate Stated Percentage Debt instrument interest rate Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument Name [Domain] Debt Instrument, Name [Domain] Debt instrument number of installment payments. Debt Instrument Number Of Installment Payments Installment period of New Note Debt Instrument Payment Terms Debt instrument payment terms Debt Instrument Periodic Payment Periodic payment of New Note Debt Instrument Redemption Description Notes redemption description Debt Instrument [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument Unamortized Discount Unamortized discount from financing obligation Value of the beneficial conversion feature related to borrowings against the Teva Note Debt Issuance Costs Total fees and expenses Deferred Rent Credit Noncurrent Deferred rent Deferred Revenue Deferred revenue Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement Type [Domain] Deferred Revenue [Domain] Deferred Revenue Current Current portion of deferred revenue Deferred Revenue Noncurrent Noncurrent portion of deferred revenues Deferred Revenue Period Increase Decrease Premium on the fair value from sale of stock, classified as deferred revenue Depreciation Depletion And Amortization Depreciation and amortization Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Share-Based Compensation Dividends Common Stock Dividends will be paid prior to the vesting of the restricted stock unit Document and entity information. Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share [Abstract] Earnings Per Share [Abstract] Earnings Per Share Basic And Diluted Basic and diluted net loss per share Earnings Per Share [Text Block] Net Loss per Share Eligible cash receipt for additional milestone payments. Eligible Cash Receipt For Additional Milestone Payments Eligible receipt of additional milestone payments Eligible cash receipt for milestone payments. Eligible Cash Receipt For Milestone Payments Eligible receipt of additional payments Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 Expenses expected to be recognized over a weighted average period Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Total unrecognized compensation expense Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Total unrecognized compensation expense related to unvested stock option awards Employee Stock [Member] Employee Stock Purchase Plan [Member] Employee Stock Option [Member] Stock options [Member] Employee Stock Purchase Plan Current Offering Period Employee Stock Purchase Plan Current Offering Period Employee stock purchase plan fixed offering period Entity Central Index Key Entity Central Index Key Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Equity Incentive Plan Effective Date Equity Incentive Plan Effective Date Effective date of Equity Incentive Plan 2005 and closing date of company's initial public offering Estimated performance period of agreement. Estimated Performance Period Of Agreement Estimated performance period of agreement Evergreen Provisions Of Directors Plan [Member] Evergreen Provisions Of Directors Plan [Member] Evergreen Provisions of Director's Plan [Member] Evergreen Provisions Of Two Thousand Five Plan [Member] Evergreen Provisions Of Two Thousand Five Plan [Member] Evergreen Provisions of 2005 Plan [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] Asset Class [Domain] Fair Value Assumptions Expected Dividend Rate Estimated debt yield Expected dividend yield Fair Value Assumptions Expected Term Estimated life of the warrant Fair Value Assumptions Expected Volatility Rate Expected volatility rate Fair Value Assumptions Risk Free Interest Rate Risk-free interest rate Fair Value By Asset Class [Axis] Asset Class [Axis] Fair Value By Fair Value Hierarchy Level [Axis] Fair Value, Hierarchy [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Accounting Fair Value Inputs Discount Rate Cash flow discount rate Fair Value Inputs Level 1 [Member] Level 1 [Member] Fair Value Inputs Level 2 [Member] Level 2 [Member] Fair Value Inputs Level 3 [Member] Level 3 [Member] Fair Value Liabilities Measured On Recurring Basis Obligations Estimated fair value of financing obligations Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block] Fair Value Measurement of Contingent Consideration Liability Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings Adjustments to fair value measurement Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Payments made Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending balance Beginning balance Gain Loss On Disposition Of Assets Gain on disposal of property General And Administrative Expense General and administrative Grupo Ferrer. Grupo Ferrer [Member] Grupo Ferrer Internacional, S.A. [Member] Guarantee Obligations Term Guarantee of notes Income Statement [Abstract] Income Statement [Abstract] Increase Decrease In Accounts Payable Accounts payable Increase Decrease In Accrued Liabilities Accrued clinical and other accrued liabilities Increase Decrease In Deferred Revenue Deferred revenues Increase Decrease In Inventories Inventory Increase Decrease In Net Loss Per Share Resulted From Change In Fair Value Of Contingent Liability Increase Decrease In Net Loss Per Share Resulted From Change In Fair Value Of Contingent Liability Increase (decrease) to the net loss, per share Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase Decrease In Other Noncurrent Assets Other assets Increase Decrease In Other Operating Liabilities Other liabilities Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other current assets Increase Decrease In Receivables Receivables Interest and other income/ (expense), net. Interest And Other Income Expense Net Interest and other income/ (expense), net Interest Expense Interest expense Interest expenses amortization period. Interest Expenses Amortization Period Interest expense amortization period Interest Reserve Interest Reserve Interest reserve Interest Reserve Description Interest Reserve Description Interest reserve description Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Inventory Finished Goods Net Of Reserves Finished goods Inventory Net Inventory Total inventory Inventory Policy [Text Block] Inventory Inventory Raw Materials Net Of Reserves Raw materials Inventory Work In Process Net Of Reserves Work in process Lease Expiration Date 1 Expiry of lease of Building Leases [Abstract] Leases [Abstract] Leases Of Lessee Disclosure [Text Block] Facility Leases Liabilities And Stockholders Equity Total liabilities and stockholders' equity Liabilities And Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' DEFICIT Liabilities Current Total current liabilities Liabilities Current [Abstract] Current liabilities: Liabilities Fair Value Disclosure [Abstract] Liabilities Liabilities Fair Value Disclosure Recurring Total liabilities License Agreements [Line Items] License Agreements [Line Items] License Agreements [Line Items] License Agreements [Table] License Agreements [Table] License Agreements [Table] License agreement term period. License Agreement Term Period License agreement term period Long Term Debt Total Long Term Debt And Capital Lease Obligations Current Book value of financing obligations Long Term Debt Maturities Repayments Of Principal After Year Five Thereafter Long Term Debt Maturities Repayments Of Principal In Year Five 2018 Long Term Debt Maturities Repayments Of Principal In Year Four 2017 Long Term Debt Maturities Repayments Of Principal In Year Three 2016 Long Term Debt Maturities Repayments Of Principal In Year Two 2015 Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year 2014 - remaining 6 months Long Term Debt Maturity Year Long Term Debt Maturity Year Royalty securitization financing legal maturity date Longterm Debt Type [Axis] Long-term Debt, Type [Axis] Longterm Debt Type [Domain] Long-term Debt, Type [Domain] Long Term Notes Payable Noncurrent portion of financing obligations Manufacturing Costs Each additional manufacturing cell cost Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Money Market Funds [Member] Money market funds [Member] Net Cash Provided By Used In Financing Activities [Abstract] Cash flows from financing activities: Net Cash Provided By Used In Financing Activities Continuing Operations Net cash provided by financing activities Net Cash Provided By Used In Investing Activities [Abstract] Cash flows from investing activities: Net Cash Provided By Used In Investing Activities Continuing Operations Net cash provided by (used in) investing activities Net Cash Provided By Used In Operating Activities [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities Continuing Operations Net cash used in operating activities Net Income Loss Net loss Net loss New Accounting Pronouncements Policy Policy [Text Block] New Accounting Pronouncement New Note [Member] New Note [Member] New Note [Member] Notes Issued 1 Non-recourse notes issued Notes Payable Current Current portion of financing obligations Chemical heat packages produced. Number Of Chemical Heat Packages Produced Production of Chemical Heat Packages Number of lease renewal options. Number Of Lease Renewal Options Number of lease renewal options Number Of Manufacturing Facilities Number Of Manufacturing Facilities Number of manufacturing cells built Number Of Operating Segments Number of business segment Operating Income Loss Loss from operations Operating Leases Maturity Period Operating Leases Maturity Period Operating leases maturity period Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] The Company and Basis of Presentation Original Note [Member] Original Note [Member] Original Note [Member] Other Accrued Liabilities Current Other accrued expenses Other Assets Noncurrent Other assets Other Comprehensive Income Loss Net Of Tax Comprehensive loss Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Other Comprehensive Loss Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Change in unrealized gain/(loss) on marketable securities Other Liabilities Fair Value Disclosure Contingent consideration liability Other Liabilities Noncurrent Other noncurrent liabilities Payment For Contingent Consideration Business Acquisition Payment For Contingent Consideration Business Acquisition Payment on contingent consideration liability Payments To Acquire Available For Sale Securities Purchases of available-for-sale securities Payments To Acquire Productive Assets Amount of cash paid to Autoliv ASP, Inc. Payments To Acquire Property Plant And Equipment Purchases of property and equipment Payments to former stockholders under collaborative arrangement. Payments To Former Stockholders Under Collaborative Arrangement Payments to former stockholders under collaborative arrangement Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Preferred Stock Value Preferred stock Prepaid Expense And Other Assets Current Prepaid expenses and other current assets Private Placement [Member] Private Placement [Member] Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock and warrants and exercise of stock options and stock purchase rights Proceeds From Issuance Of Long Term Debt Borrowing under loan agreement Proceeds from financing obligations, net of issuance costs Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities Maturities of available-for-sale securities Proceeds From Repayments Of Restricted Cash Financing Activities Change in restricted cash Proceeds From Sale Of Available For Sale Securities Sales of marketable securities Proceeds From Sale Of Property Plant And Equipment Proceeds from sale of property and equipment Property Plant And Equipment Net Property and equipment, net Purchase price to eliminate contingent consideration under collaborative arrangement. Purchase Price To Eliminate Contingent Consideration Under Collaborative Arrangement Purchase of common stock, value Range [Axis] Range [Axis] Range [Member] Range [Domain] Receivables Net Current Receivables Repayments Of Long Term Debt And Capital Securities Payments of financing obligations Research And Development Arrangement Contract To Perform For Others Description And Terms License agreement contractual terms Research And Development Expense Research and development Restricted Cash Amortized Cost Restricted Cash Amortized Cost Less amounts classified as restricted cash, Amortized Cost Restricted Cash And Cash Equivalents Noncurrent Restricted cash Restricted Cash Fair Value Disclosure Restricted Cash Fair Value Disclosure Less amounts classified as restricted cash, Fair Value Restricted Stock Units R S U [Member] Restricted Stock Units [Member] Retained Earnings Accumulated Deficit Deficit accumulated during development stage Revenue Recognition Milestone Method Revenue Recognized Upfront cash received under collaborative arrangement Revenue Recognition Policy [Text Block] Revenue Recognition Revenues Total revenue Right To Borrow Asset Reclassified As Debt Discount Right To Borrow Asset Reclassified As Debt Discount Value of right-to-borrow asset reclassified as debt discount Sale Of Stock Name Of Transaction [Domain] Sale of Stock [Domain] Sales Revenue Goods Net Product sales Sales Revenue Net Collaboration revenue Revenue under agreement Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Anti-Dilutive Securities Excluded from Net Loss per Share Schedule Of Cash Cash Equivalents And Short Term Investments Table [Text Block] Schedule of Cash Equivalents and Marketable Securities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block] Financial Assets by Major Security Type and Liability Measured at Fair Value on Recurring Basis Schedule Of Inventory Current Table [Text Block] Schedule of Inventory Schedule Of Maturities Of Long Term Debt Table [Text Block] Long Term Debt Payments by Year Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block] Summary of Restricted Stock Unit Activity under Company's Share-Based Compensation Plans Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Option Activity under Company's Share-Based Compensation Plans Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Estimated Grant Date Fair Values of Stock Options with Weighted Average Assumptions Secured Debt Financing from royalty securitization Securities Assets [Member] Total [Member] Share Based Compensation Share-based compensation Share based compensation arrangement award maximum annual additional shares. Share Based Compensation Arrangement Award Maximum Annual Additional Shares Increase in annual reserve by shares of common stock Share based compensation arrangement award maximum contractual term. Share Based Compensation Arrangement Award Maximum Contractual Term Maximum contractual term for issuing new grants stock options and restricted stock units Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period 1 Vesting period for stock options and restricted stock units Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Forfeited, Number Of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Forfeited, Weighted Average Grant-Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Granted, Number Of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Granted, Weighted Average Grant-Date Fair Value Stock units Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Outstanding at June 30, 2014, Number Of Shares Outstanding at January 1, 2014, Number Of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Outstanding at June 30, 2014, Weighted Average Grant-Date Fair Value Outstanding at January 1, 2014, Weighted Average Grant-Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Released, Number Of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Released, Weighted Average Grant-Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend yield Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term 1 Expected term Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Expected volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Risk-free interest rate Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized Authorized shares of common stock for issuance, Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares available for issuance Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Intrinsic value of options exercised Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Options canceled, Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Options granted, Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Stock options Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Table [Text Block] Weighted Average Fair Value of Employee Stock Options Granted Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Outstanding at June 30, 2014, Number of Shares Outstanding at January 1, 2014, Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Outstanding at June 30, 2014 , Weighted Average Exercise Price Outstanding at January 1, 2014, Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum Increase in annual reserve by percentage of shares of common stock Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased Weighted average price Share Based Compensation Arrangement By Share Based Payment Award Proposed Shares Reserved For Future Issuance Share Based Compensation Arrangement By Share Based Payment Award Proposed Shares Reserved For Future Issuance Shares authorized for issuance include annual reserve Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Employees purchase common stock on their enrollment date Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Equity Award [Domain] Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Options exercised, Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price Options canceled, Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Options granted, Weighted Average Exercise Price Shareholders Equity And Share Based Payments [Text Block] Share-Based Compensation Plans Share Price Common stock price, per share Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Significant Purchase And Supply Commitment Excluding Longterm Commitment [Text Block] Autoliv Manufacturing and Supply Agreement Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Stockholders Equity Total stockholders' deficit Stockholders Equity [Abstract] Stockholders' deficit: Stock Issued During Period Shares New Issues Aggregate purchase price Stock Issued During Period Shares Share Based Compensation Shares issued under ESPP Stock Issued During Period Shares Stock Options Exercised Options exercised, Number of Shares Stock Purchase Rights [Member] Stock Purchase Rights [Member] Stock Purchase Rights [Member] Subsidiary Sale Of Stock [Axis] Sale of Stock [Axis] Supplemental Cash Flow Elements [Abstract] Supplemental disclosure of cash flow information Term loan agreement fair value of outstanding borrowings. Term Loan Agreement Fair Value Of Outstanding Borrowings Fair value of right-to-borrow note Teva Pharmaceuticals USA, Inc. Teva Pharmaceuticals Usa Inc [Member] Teva Pharmaceuticals USA, Inc. [Member] Trading Symbol Trading Symbol Two Thousand And Five Employee Stock Purchase Plan [Member] Two Thousand And Five Employee Stock Purchase Plan [Member] 2005 Employee Stock Purchase Plan [Member] Two Thousand And Five Equity Incentive Plan [Member] Two Thousand And Five Equity Incentive Plan [Member] 2005 Equity Incentive Plan [Member] Two Thousand And Five Non Employee Directors Stock Option Plan [Member] Two Thousand And Five Non Employee Directors Stock Option Plan [Member] 2005 Non-Employee Director's Stock Option Plan [Member] Type Of Arrangement [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Unamortized Debt Issuance Expense Unamortized borrowing cost from financing obligation Unsecured Debt Value of unsecured promissory note issued Unvested Restricted Stock Units [Member] Unvested Restricted Stock Units [Member] Unvested restricted stock units [Member] Unvested Stock Option Awards [Member] Unvested Stock Option Awards [Member] Unvested stock option awards [Member] Upfront cash received under collaborative arrangement. Upfront Cash Received Under Collaborative Arrangement Upfront cash received under collaborative arrangement Up Front Payment Arrangement [Member] Upfront payment [Member] Warrant [Member] Warrants to purchase common stock [Member] Warrants Not Settleable In Cash Fair Value Disclosure Total value of warrants Value of warrants issued with royalty securitization financing Weighted Average Cost Of Capital Weighted Average Cost Of Capital Change in percentage of WACC Weighted Average Number Of Share Outstanding Basic And Diluted Shares used to compute basic and diluted net loss per share